1-(5-isoquinolinesulfonyl)piperazine has been researched along with n-(2-aminoethyl)-5-isoquinolinesulfonamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gesquiere, JC; Ricouart, A; Sergheraert, C; Tartar, A | 1 |
| Gerena, L; Geyer, JA; Keenan, SM; Waters, NC; Welsh, WJ; Woodard, CL | 1 |
2 other study(ies) available for 1-(5-isoquinolinesulfonyl)piperazine and n-(2-aminoethyl)-5-isoquinolinesulfonamide
| Article | Year |
|---|---|
Design of potent protein kinase inhibitors using the bisubstrate approach.
Topics: Adenosine Triphosphate; Binding Sites; Drug Design; Enzyme Inhibitors; Isoquinolines; Kinetics; Molecular Structure; Protein Kinase C; Protein Kinase Inhibitors; Structure-Activity Relationship; Substrate Specificity; Sulfonamides | 1991 |
Evaluation of broad spectrum protein kinase inhibitors to probe the architecture of the malarial cyclin dependent protein kinase Pfmrk.
Topics: Animals; Binding Sites; Crystallography, X-Ray; Cyclic AMP-Dependent Protein Kinases; Cyclin-Dependent Kinases; Drug Evaluation, Preclinical; Enzyme Inhibitors; Inhibitory Concentration 50; Ligands; Malaria; Molecular Conformation; Naphthalenes; Plasmodium falciparum; Sulfonamides | 2007 |